Transient acute depression induced by high-frequency deep-brain stimulation.

Continuous high-frequency stimulation of the basal ganglia was recently introduced for the treatment of patients with advanced Parkinson's disease.1 This treatment seems to be most effective when the electrodes are placed in the subthalamic nuclei.2,3 Among the 20 patients treated successfully by bilateral subthalamic stimulation at our center, 1 woman had transient acute depression when high-frequency stimulation was delivered to the left substantia nigra, 2 mm below the site where stimulation alleviated the signs of Parkinson's disease. We describe here the results of detailed studies of the induction of major, reversible depression in this woman. Case Report A 65-year-old . . .

[1]  A. Benabid,et al.  Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.

[2]  G. Schaltenbrand,et al.  Atlas for Stereotaxy of the Human Brain , 1977 .

[3]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[4]  J. Andersson,et al.  Brain correlates of an unexpected panic attack: a human positron emission tomographic study , 1998, Neuroscience Letters.

[5]  P. Goldman-Rakic,et al.  Organization of the nigrothalamocortical system in the rhesus monkey , 1985, The Journal of comparative neurology.

[6]  A. Lang,et al.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.

[7]  A. Benabid,et al.  Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus , 1991, The Lancet.

[8]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[9]  A. D. Smith,et al.  The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat , 1996, Neuroscience.

[10]  Y. Agid,et al.  Pallidal stimulation for Parkinson's disease , 1997, Neurology.

[11]  M. Raichle,et al.  Neural correlates of self-induced dysphoria. , 1993, The American journal of psychiatry.

[12]  C. Wallesch,et al.  Poststroke depression. Is there a pathoanatomic correlate for depression in the postacute stage of stroke? , 1995, Stroke.

[13]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[14]  H. Manji,et al.  The pharmacologic treatment of depression. , 1991, The New England journal of medicine.

[15]  P. Goldman-Rakic,et al.  The primate mediodorsal (MD) nucleus and its projection to the frontal lobe , 1985, The Journal of comparative neurology.

[16]  B Aubert,et al.  A technique of measuring the precision of an MR-guided stereotaxic installation using anatomic specimens. , 1994, AJNR. American journal of neuroradiology.

[17]  R. Robinson,et al.  Mood disorders in stroke patients. Importance of location of lesion. , 1984, Brain : a journal of neurology.

[18]  J. Pardo,et al.  Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Adolphs,et al.  Fear and the human amygdala , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  H. Mayberg,et al.  Depression in Parkinson's disease: a biochemical and organic viewpoint. , 1995, Advances in neurology.

[21]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[22]  M. Mintun,et al.  A Noninvasive Approach to Quantitative Functional Brain Mapping with H215O and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Richard S. J. Frackowiak,et al.  Knowing where and getting there: a human navigation network. , 1998, Science.